-
Advanced and Metastatic Breast Cancer
846
global
1
0.25
9
0.25
0.25
Commentary
0
1
Hematology-Oncology2023-03-22 20:00:00
Aromatase inhibitors (AIs), selective estrogen receptor modulators (SERMs), and selective estrogen receptor degraders (SERDs). How do they work and when should they be added to the treatment of metastatic hormone receptor (HR)-positive breast cancer?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Breast Cancer
840
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-03-20 20:00:00
Do you know the best approaches for identifying and managing high-risk, hormone receptor positive early breast cancer?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
0
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-03-20 20:00:00
Did you know that pyruvate kinase deficiency (PKD) is diagnosed using a combination of PK enzyme activity and PKLR molecular profiling?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Chronic Lymphocytic Leukemia
1551
global
1
0.75
9
0.75
0.75
Commentary
0
1
Hematology-Oncology2023-03-20 20:00:00
Did you know noncovalent BTK inhibitor therapy is now an option for patients with pretreated MCL who fail a prior covalent BTK inhibitor therapy?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Chronic Myelogenous Leukemia
1552
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-19 20:00:00
How do you choose a tyrosine kinase inhibitor (TKI) for your patients with chronic myeloid leukemia (CML)? Join to hear an expert discussion on considerations and clinical data.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Colorectal Cancer
3032296
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-19 20:00:00
Did you know that patients with left-sided colorectal cancer (CRC) tend to have greater overexpression of human epidermal growth factor receptor-2 (HER2) than those with right-sided disease?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Advanced and Metastatic Breast Cancer
846
global
1
0.25
9
0.25
0.25
Commentary
0
1
Hematology-Oncology2023-03-22 20:00:00
Aromatase inhibitors (AIs), selective estrogen receptor modulators (SERMs), and selective estrogen receptor degraders (SERDs). How do they work and when should they be added to the treatment of metastatic hormone receptor (HR)-positive breast cancer?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Breast Cancer
840
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-03-20 20:00:00
Do you know the best approaches for identifying and managing high-risk, hormone receptor positive early breast cancer?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
0
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-03-20 20:00:00
Did you know that pyruvate kinase deficiency (PKD) is diagnosed using a combination of PK enzyme activity and PKLR molecular profiling?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Chronic Lymphocytic Leukemia
1551
global
1
0.75
9
0.75
0.75
Commentary
0
1
Hematology-Oncology2023-03-20 20:00:00
Did you know noncovalent BTK inhibitor therapy is now an option for patients with pretreated MCL who fail a prior covalent BTK inhibitor therapy?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Chronic Myelogenous Leukemia
1552
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-19 20:00:00
How do you choose a tyrosine kinase inhibitor (TKI) for your patients with chronic myeloid leukemia (CML)? Join to hear an expert discussion on considerations and clinical data.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Colorectal Cancer
3032296
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-19 20:00:00
Did you know that patients with left-sided colorectal cancer (CRC) tend to have greater overexpression of human epidermal growth factor receptor-2 (HER2) than those with right-sided disease?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Graft Versus Host Disease and Transplant Complications
6012552
global
1
0.75
0.75
Roundtable
0
1
Hematology-Oncology2023-03-19 20:00:00
Are you up to date on emerging complement-blocking therapies for hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA)?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Multiple Myeloma
1166
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-03-16 20:00:00
How do you tailor treatment to the individual patient with newly diagnosed multiple myeloma (MM)?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Multiple Myeloma
1166
global
1
1.0
9
1.0
1.0
Journal Article
0
1
Hematology-Oncology2023-03-15 20:00:00
In the era of risk-adapted treatment strategies, it is crucial to detect del(1p32) at multiple myeloma diagnosis, suggests a cytogenetic study.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Chronic Kidney Disease
727
global
1
0.5
9
0.5
0.5
Clinical Review
0
1
Nephrology2023-03-15 20:00:00
What are the current treatment strategies for patients with chronic kidney disease (CKD) experiencing anemia?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Hepatocellular Carcinoma
3032322
global
1
0.75
9
0.75
0.75
Roundtable
0
1
Hematology-Oncology2023-03-13 20:00:00
Did you know that radiopharmaceuticals for the treatment of metastatic castration-resistant prostate cancer (mCRPC) care have the potential to prolong survival and optimize the quality of life?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Advanced and Metastatic Breast Cancer
846
us
1
1.0
1.0
Clinical Case
0
1
Pathology & Lab Medicine2023-03-13 20:00:00
Are you up to date with the latest guidance and best practices in breast cancer human epidermal growth factor receptor 2 (HER2) testing? Learn more here!
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-12 20:00:00
Did you know Black women have the highest breast cancer mortality rate of any racial/ethnic group?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Bladder Cancer
821
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-09 19:00:00
Get the latest data on prostate and bladder cancer from the 2023 winter meetings.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Head and Neck Cancer
3004984
global
1
1.0
9
1.0
2
1.0
1.0
Clinical Review
0
1
Hematology-Oncology2023-03-09 19:00:00
Did you know that targeted agents and immunotherapies are improving outcomes in patients with low-grade and high-grade brain tumors?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Bowel Preparation
5000040
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
1
Hematology-Oncology2023-03-09 19:00:00
A new study analyzes the rate of colonoscopies performed following a positive stool test.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Chronic Kidney Disease
727
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Infectious Diseases2023-03-08 19:00:00
Which specialists should be on your team in order to effectively manage anemia in patients with chronic kidney disease (CKD)?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Melanoma
65
global
1
0.25
9
0.25
0.25
Commentary
0
1
Hematology-Oncology2023-03-08 19:00:00
Do you know the role of lymphocytic activation gene 3 (LAG3) in metastatic melanoma and its potential as a treatment target?
0.25ABIM MOC
0.25CME/CE
15MIN
Save